Nationwide Children's Research News
Viewing: 151-160 of 380 | All
Dec 11, 2017
Injuries from Window Blinds Send Two Children to the Emergency Department Every Day
Most homes have them. They help keep our rooms warm or cold and even add a pop of color to tie the décor together. But window blinds can cause serious injuries or even death to young children.
Nov 01, 2017
Phase 1 Study Shows Encouraging Data for Gene Replacement Therapy for Spinal Muscular Atrophy Type 1
A one-time intravenous infusion of the high dose of gene therapy extended the survival of patients with spinal muscular atrophy type 1 (SMA1) in a Phase 1 clinical trial, according to a study published today in the New England Journal of Medicine. The study was conducted by Researchers from Nationwide Children’s Hospital in collaboration with AveXis, Inc. and The Ohio State University College of Medicine.
Sep 28, 2017
Hyundai Hope On Wheels Awards $250,000 Research Grant To Nationwide Children's Hospital In Honor Of National Childhood Cancer Awareness Month
Hyundai Hope On Wheels® will today present Nationwide Children's Hospital with a $250,000 Hyundai Scholar Hope Grant. The grant funds will support the research of Timothy Cripe, MD, PhD, principal investigator and division chief of Hematology/Oncology and BMT. Dr.
Sep 15, 2017
A New Paradigm for Treating Transcription Factor-Driven Cancers
In the current issue of Proceedings of the National Academy of Sciences, researchers from Nationwide Children’s Hospital describe a new paradigm for treating transcription factor-driven cancers.
Sep 05, 2017
Nationwide Childrens Hospital First To Implement New International Cerebral Palsy Guidelines
While diagnosis of cerebral palsy typically occurs when children are 2 years of age or older, Nationwide Children’s has decreased the average age of diagnosis to 13 months, allowing for earlier therapy.
Jul 12, 2017
Study Finds Rate of Medication Errors Resulting in Serious Medical Outcomes Rising
About every two minutes someone in the United States calls Poison Control because of a medication error. A new study from the Center for Injury Research and Policy and the Central Ohio Poison Center at Nationwide Children’s Hospital analyzed calls to Poison Control Centers across the country
Jun 19, 2017
Combining Immunotherapies Effective Against Mouse Model of Cancer
Rhabdomyosarcoma, a cancer made up of cells that normally develop into skeletal muscles, is the most common soft tissue cancer in children. If it is detected early and localized in certain areas, rhabdomyosarcoma is usually curable with traditional therapies like surgery, radiation and
Jun 12, 2017
Immune Profiling Leads to Implications for Immunotherapy for NF1-Associated Tumors
Neurofibromatosis type 1 (NF1) — an autosomal dominant disorder affecting approximately one in every 3,500 people — results in dysfunctional neurofibromin, a protein expressed throughout the body and involved in the RAS signaling pathway.
Jun 08, 2017
MEDIA ADVISORY: Fifth Annual International Central Nervous System Germ Cell Tumor Conference
MEDIA ADVISORY WHAT: Fifth Annual International Central Nervous System Germ Cell Tumor Conference hosted by Nationwide Children’s Hospital. Germ cells are a specific cell that grows during the development of a fetus. These cells go on to become sperm in the testicles or eggs in the ovaries.
May 30, 2017
Mardis Receives Prestigious Luminary Award
The Precision Medicine World Conference has awarded Elaine R. Mardis, PhD, with a 2017 Luminary Award, recognizing her for her role in shaping health care through her leading work in genome sequencing and therapeutic application development.